Rapport Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RAPP and other ETFs, options, and stocks.

About RAPP

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.

CEO

Abraham N. Ceesay

CEOAbraham N. Ceesay

Employees

Employees69

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2022

Founded2022

Employees

Employees69

RAPP Key Statistics

Market cap

817.74M

Market cap817.74M

Price-Earnings ratio

-11.38

Price-Earnings ratio-11.38

Dividend yield

—

Dividend yield—

Average volume

1.83M

Average volume1.83M

High today

$28.09

High today$28.09

Low today

$22.36

Low today$22.36

Open price

$24.08

Open price$24.08

Volume

5.41M

Volume5.41M

52 Week high

$42.27

52 Week high$42.27

52 Week low

$6.43

52 Week low$6.43

Analyst ratings

100%

of 6 ratings

Buy

100%

Hold

Sell

People also own

Based on the portfolios of people who own RAPP. This list is generated using Robinhood data, and it’s not a recommendation.

D-Wave Quantum

Rigetti Computing

SoundHound AI

Opendoor Technologies

Super Micro Computer

BigBear.ai

Rapport Therapeutics

Why Robinhood?

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. Show more

RAPP Key Statistics

Analyst ratings

100%

People also own

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform.